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CASE PRESENTATION
A 52-year-old man with a past medical history of asthma,
well-controlled diabetes and hypertension was referred to
our hospital for acute renal failure. The patient reported a
2-month history of fatigue and arthralgia involving his
shoulders, elbows, wrists, metacarpophalangeal joints as well
as his knees and ankles. Six weeks before admission, he
started naproxen 400 mg twice daily without improvement.
Subsequently he was evaluated by a local rheumatologist who
suspected rheumatoid arthritis and started him on prednisone
30 mg daily. A month later, his laboratories revealed an
elevated serum creatinine (12.3 mg/dl, 1087mmol/l) and
potassium (7.9 mEq/l). His serum creatinine was 1.8 mg/dl
(159.1mmol/l) 6 weeks earlier and 1.3 mg/dl 7 years earlier
(Figure 1). The hyperkalemia was treated with intravenous
insulin and dextrose, and he was admitted to our hospital for
further management. He denied fever, chills, weight loss,
shortness of breath, lower extremity edema, and did not have
any uremic symptoms (no nausea, vomiting, hiccups, or
itching). He had normal urine output and no dysuria or
hematuria. He had hypertension that was diagnosed 13 years
earlier and based on records it was well controlled (o135/85)
on enalapril 10 mg daily. His diabetes was diagnosed 4 months
earlier and treated with rosiglitazone 4 mg once daily.
He had not been evaluated for retinopathy. He had no
prior urine analysis to assess the presence of albuminuria. His
other medications included fluticasone aerosol, albuterol/
ipratropium puffs, acetaminophen two tablets at bedtime, and
prednisone 30 mg daily. On physical exam his initial blood
pressure was 162/70 with a heart rate of 102/min, regular.
Orthostatic blood pressure was not checked. He was afebrile.
His mucous membranes were moist. His cardiac exam was
normal with no pericardial rub and jugular veins were flat. His
lungs were clear and abdomen soft with no organomegaly.
The skin was normal. His joint exam revealed synovitis in his
elbows, wrists, metacarpophalangeal joints, knees, and ankles
bilaterally. He had stiffness and decreased range of motion in
his elbows, wrists, and ankles. His admission laboratories are
shown in Table 1A and 1B.
Hospital course
Patient was admitted to the intensive care unit and
nephrology was consulted. He was started on dialysis through
a right internal jugular dialysis catheter because of hyper-
kalemia and azotemia. His angiotensin converting enzyme
inhibitor (ACEI) medication and non-steroidal anti-inflam-
matory drugs (NSAID) were stopped.
Further tests in the hospital revealed C3 138 mg/dl (normal
75–175), total complement 67 U/ml (30–75), rheumatoid factor
o15 IU/ml (o15), antinuclear antibodies 0.2 U (o1), myelo-
peroxidase antibody less then 5 EU/ml (o5), and proteinase
less then 5 EU/ml (o5). Serologies for hepatitis B and C were
negative. Serum protein electrophoresis showed a total protein
of 6.6 g/dl (normal 6.3–7.9), albumin 3.2 g/dl (3.4–4.7), a-1
globulin 0.5 g/dl (0.1–0.3), a-2 globulin 1.4 g/dl (0.6–1),
b-globulin 1 g/dl (0.7–1.2) and g-globulin 0.5 g/dl (0.6–1.6).
Urinalysis showed a protein to osmolality ratio of 1.17 that
corresponds to 24-h urine protein of 1.1 g. The urinary
sediment was unremarkable with no red or white blood cell
casts. His kidney ultrasound showed no hydronephrosis,
normal corticomedullary differentiation, and no renal masses.
The left kidney was 13.8 cm and the right 13.6 cm in length. His
chest X-ray was unremarkable.
The nephrologist felt initially that the acute renal failure
was secondary to the combination of NSAID and ACEI
toxicities in the setting of chronic kidney disease related to
diabetes and hypertension. The anemia was felt to be
multifactorial related to chronic kidney disease, iron
deficiency, and inflammation. His calcium was not elevated
to suggest multiple myeloma.
During his hospital course, he was nonoliguric but
remained dialysis dependent. In addition, he complained of
bilateral hand weakness and numbness (involving the thumb
and index finger) and was diagnosed with severe bilateral
carpal tunnel syndrome that was confirmed on electromyo-
graphy. He underwent a carpal tunnel release surgery with
significant improvement in his symptoms.
A kidney biopsy was performed because of persistence of
the renal failure.
KIDNEY BIOPSY FINDINGS
Light microscopy
There were 10 glomeruli present, none of which were globally
sclerosed. The glomeruli showed mild mesangial expansion
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with increase in mesangial matrix; however, mesangial
nodules were not seen (Figure 2a). The glomerular basement
membranes appeared slightly thickened. However, double
contours, basement membrane spikes, or pinholes were not
evident. The glomeruli did not show any inflammatory
features and crescents, fibrinoid necrosis, thrombosis, or
endocapillary proliferation was not present.
Tubules and interstitium. There was extensive tubulo-
interstitial disease present. Tubules showed degenerative
changes with distention, flattened epithelium, and debris in
the lumen. A few tubules contained periodic acid Schiff
(PAS)-negative protein reabsorption-like droplets both in the
tubular epithelial cells and between the epithelial cells (Figure
2b, arrows). A few tubules contained PAS-positive hyaline
casts, while isolated tubules also contained PAS-negative casts
(Figure 2c, arrow). The casts did not have a lamellated or
fractured appearance and an inflammatory reaction around
the casts was not present. In a few tubules, the PAS-negative
casts were lined by protein reabsorption-like droplets (Figure
2b, arrowheads). The tubular basement membranes were
thickened, there was moderate chronic interstitial inflamma-
tion present, and approximately 70% of the sample showed
tubular atrophy and interstitial fibrosis.
Vessels. Arteries and arterioles showed moderate sclerosis
of the vessel walls. PAS-negative material was not present
along the vessel walls.
Congo-red stains showed positive reddish-brown amyloid
material with apple-green birefringence staining of the
protein reabsorption-like droplets in few tubules (Figure
3a). In a few tubules, casts were also Congo-red positive and
showed spicule-like arrangement (Figure 3b). Congo-red
stains were negative in the glomeruli, interstitium, and
vessels.
Immunofluorescence microscopy
Seven glomeruli were present, all of which were negative for
immune deposits. A few tubules contained casts that stained
for l-light chains (Figure 4a) but were negative for k-light
chains (Figure 4b).
Electron microscopy
Ultrastructural studies of the glomeruli showed mild focal
effacement of the foot processes of the visceral epithelial cells.
Electron dense deposits were not present along the capillary
walls. The glomerular basement membranes were slightly
thickened but did not show any infiltration by amyloid fibrils.
Also, fine granular deposits to suggest light chains were not
seen along the glomerular basement membranes. The
mesangium showed mild increase in matrix, but amyloid
fibrils were not seen in the mesangium. Examination of the
tubules revealed large collections of amyloid fibrils within and
between the tubular epithelial cells and in the lumen forming
amyloid droplets (Figure 5). The fibrils measured 12 nm in
thickness. Blood vessels showed no amyloid in the vessel walls.
Renal biopsy diagnosis
(1) Primary (AL) amyloidosis, l-light chain type, present
primarily within tubules. (2) Interstitial nephritis, chronic,
with extensive tubular atrophy and interstitial fibrosis.
(3) Early diabetic glomerulosclerosis.
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Figure 1 | Serum creatinine trend. Serum creatinine levels over time.
Table 1A | Laboratory data at presentation
Blood test (unit)
Reference
range
On
admission
Hemoglobin (g/dl) 13.5–17.5 9.4
MCV (fl) 81.2–95.1 84
White blood count ( 109/l) 3.5–10.5 7.2
Platelets ( 109/l) 150–450 325
Reticulocytes counts (%) 0.6–1.83 1.04
Absolute reticulocytes counts ( 109/l) 29.5–87.3 31.8
Sediment rate (mm/1 h) 0–22 51
Vitamin B12 (ng/l) 180–914 396
Folate (mg/l) 43.5 7.2
Iron (mg/dl) 50–150 22
Total iron binding capacity (mg/dl) 250–400 258
Transferrin saturation (%) 14–50 9
Ferritin (mg/l) 14–336 554
Sodium (mmol/l) 135–145 131
Potassium (mmol/l) 3.6–4.8 7.9
Chloride (mmol/l) 100–108 104
Bicarbonate (mmol/l) 22–29 11
Blood urea nitrogen (mg/dl) 8–24 166
Creatinine (mg/dl) 0.8–1.3 12.3
Ionized calcium (mg/dl) 4.8–5.7 5.44
Phosphorus (mg/dl) 2.5–4.5 9.7
Magnesium (mg/dl) 1.7–2.1 2.2
Albumin (g/dl) 3.5–5 3.9
Glucose (mg/dl) 70–100 142
Glycosylated hemoglobin (%) 4–6 6.4
Creatinine kinase (U/l) 52–336 91
ALT (U/l) 10–45 17
Alkaline phosphatase (U/l) 45–115 97
ALT, alanine aminotransferase; MCV, mean corpuscular volume.
Table 1B | Laboratory data at presentation
Urine analysis (reference value and unit)
Appearance Normal
Osmolality (300–800 mOsm/kg) 298
Protein (o150 mg/dl) 33
Protein/osmolality ratio (o0.12) 1.17
Predicted 24 h protein (mg/24 h) 1100
Leucocytes (1–3 per high-power field) None
Red blood cell (o1 per high-power field) 1–3
Hyaline casts None
Granular casts None
Gram stain (negative) Negative
Nitrates (negative) Negative
Sodium (mmol/l) 46
Creatinine (mg/dl) 55
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CLINICAL FOLLOW-UP
In the light of the kidney biopsy results, serum immunofixa-
tion electrophoresis was performed that showed monoclonal
l-light chains 908 mg/dl (normal 0.57–2.63 mg/dl), k-light
chains 2.72 mg/dl (normal 0.33–1.94 mg/dl), and k: lo0.01.
The b-2 microglobulin level was markedly elevated at
a
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Figure 2 | Light microscopy. PAS-stained sections showing: (a) glomeruli, (b) PAS-negative amyloid droplets in tubules (arrows) and amyloid
droplets surrounding PAS-negative casts (arrowheads), and (c) PAS-negative casts (arrow).
a b
Figure 3 | Congo red-stain. Congo-red stains showing reddish-brown positive material (a) droplets in the tubules (arrows), (b) few casts that
also stain positively with spicule formation (arrow).
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21.4 mg/ml (normal 0.7–1.8 mg/ml). The urine protein electro-
phoresis showed monoclonal M-spike. Urine immunofixa-
tion studies also showed monoclonal l-light chains.
A bone marrow biopsy was performed that showed plasma
cell myeloma with focal amyloid deposition. The marrow was
slightly hypercellular (70%) with 30% l-light chain restricted
plasma cells.
No radiographic evidence for metastasis or myeloma was
detected on a full-body scan.
A Cardiac Echo showed normal left ventricular chamber
size with a calculated left ventricular ejection fraction of 60%
and no evidence of cardiac amyloidosis.
Because of the multiple joints synovitis, a synovial
aspiration of the left knee was performed and stained with
Congo red. Amyloid was focally present within the mono-
cytic/histiocytic cells. In addition, patient complained of
recurrence of hand weakness and noted bilateral paresthesias
in the soles of his feet bilaterally and proximal toes. An
electromyography was repeated and showed evidence of a
length-dependent predominantly axonal sensorimotor per-
ipheral neuropathy. There was evidence of median and ulnar
neuropathy on the right which had slightly progressed from
the previous study. The neurologist felt that the polyneuro-
pathy was likely due to amyloidosis. In summary, the patient
had the following new diagnoses: (1) multiple myeloma and
(2) systemic AL amyloidosis with renal, joint and probable
nerve involvement.
He was started on high-dose dexamethasone on days 1–4,
9–12, and 11–20, every 28 days. He reported on the 3rd day of
treatment that he felt remarkably improved and was able to
walk with minimal difficulty. At the time of submission of the
manuscript, he was still dialysis dependent and was under-
going an evaluation for bone marrow transplantation.
DISCUSSION
We present a case of acute renal failure with rather unusual
renal biopsy findings in a patient with hypertension, diabetes,
and recent polyarthralgia presumed to be secondary to
rheumatoid arthritis (RA). The initial clinical impression was
that the renal insufficiency was due to the effects of the
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Figure 4 | Immunofluorescence microscopy. Immunofluorescence stains showing (a) positive staining for l-light chains and (b) negative
staining for k-light chains.
a b
Figure 5 | Electron microscopy. Electron microscopy showing that the droplets are made up of amyloid fibrils (a) original magnification
 4600 and (b) original magnification  17 500.
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NSAID and ACEI in the setting of diabetes mellitus and
hypertension. However, a renal biopsy was obtained because
of lack of improvement of renal function. The renal biopsy
showed chronic interstitial inflammation along with rather
extensive tubulo-interstitial scarring. Based on these findings,
the initial renal biopsy impression was that of chronic
interstitial nephritis, secondary to NSAID and ACEI. The
biopsy also showed few casts that stained for l-light chains,
suggesting a component of cast nephropathy/myeloma
kidney. The case was unusual in that the casts did not
appear histologically like those in cast nephropathy and that
tubules contained PAS-negative droplets that did not appear
like protein reabsorption droplets. They were much larger;
some were free in the lumen, others in the epithelial cells and
some between the epithelial cells. In isolated tubules, the
PAS-negative casts were surrounded by the droplets.
Surprisingly the casts and droplets stained for l-light chains,
and furthermore showed bright apple-green birefringence on
Congo-red stains suggesting that they were made of amyloid
fibrils. Electron microscopy confirmed the diagnosis of
amyloidosis: amyloid fibrils were present in tubules, both
free in the lumen comprising the casts, and within and
between tubular epithelial cells forming protein reabsorp-
tion-like droplets. A search of the literature at this time
revealed a single report of amyloid casts in the tubules.1
Light chain deposition was not seen along the tubular or
glomerular basement membranes. The thickening of the
glomerular and tubular basement membranes was likely due
to diabetes and ischemic changes from hypertension. The
tubulo-interstitial scarring was likely due to multiple
etiologies including chronic interstitial nephritis due to
NSAID or ACEI, tubular amyloidosis, diabetes, and/or
hypertension.
Work-up of renal amyloidosis
The diagnosis of amyloidosis is usually based on positive
Congo-red and/or Thioflavin T stains. Routine sub-typing of
amyloidosis into AL amyloidosis (light chain-associated
amyloid) and AA amyloidosis (secondary amyloid) is then
carried out by staining for l- and k-light chains, and stains
for serum amyloid protein and serum amyloid A protein. In
AL amyloid, the amyloid stains for serum amyloid protein
and either k- or l-light chains (as in our case). In case of AA
amyloidosis, the amyloid stains for serum amyloid protein
and serum amyloid A protein, but is negative for either light
chain. For diagnosis of rare and hereditary forms of amyloid,
serum isoelectric focusing, DNA sequencing, and mass
spectrometry are often required.
Differential diagnosis of renal failure and monoclonal
gammopathy
Monoclonal gammopathy is defined as an excessive secretion
of immunoglobulin (whole molecule or subunits) that results
from abnormal clonal proliferation of plasma cells or
B lymphocytes.2 Dysproteinemia and plasma cell dyscrasia
are other alternative terms used for monoclonal gammo-
pathy. The majority of kidney diseases in monoclonal
gammopathy are secondary to deposition of light chains (k
or l) and not heavy chains or intact immunoglobulins.3 The
spectrum of renal lesions associated with monoclonal
gammopathy is extensive and depend on the physiochemical
properties of the immunoglobulin produced.3 For example,
free light chain molecules may pass through the glomerular
basement membrane and form casts within distal tubular
lumina (myeloma cast nephropathy) or form crystals within
the cytoplasm of proximal tubules (light chain Fanconi
syndrome). Immunoglobulin molecules or subunits may also
form paraprotein tissue deposits like in amyloidosis and
monoclonal immunoglobulin deposition disease.4 The dif-
ferent causes of renal failure in monoclonal gammopathy are
listed in Table 2.
Value of serum and urine electrophoresis
Since the quantity of circulating monoclonal light chains may
be low in AL amyloidosis, immunofixation electrophoresis
rather than simple protein electrophoresis is often required to
detect the monoclonal light chains. In our case following
renal biopsy, both serum and urine immunofixation electro-
phoresis revealed monoclonal l-light chains. Quantification
of free light chains is then important not only in establishing
the monoclonal proteins but also in following disease
progression and response to treatment.6,7
Clinical and histological features of AL amyloidosis
According to a Mayo Clinic study, the incidence of AL
amyloidosis is 9 per million per year in the United States.8
Clinically, amyloidosis presents most frequently as fatigue
and weight loss.9 Many organs can be affected including the
kidneys and less frequently the heart, liver, and peripheral
nerve.9,10 Typically amyloidosis involving the kidney presents
as nephrotic-range proteinuria with or without renal
insufficiency. Sixty percent of patients with amyloid excrete
at least 1 g/day of protein. Fewer than 5% have a urinary
protein loss less than 150 mg/day. The urinary sediment in
amyloidosis is usually bland as in our case, showing only fat
or fatty acid crystals.11 Key clinical features and syndromes of
AL amyloidosis at presentation are summarized in Table 3A
and 3B.
Amyloid can be found anywhere in the kidney, but
glomerular deposition typically predominates. By light
Table 2 | Differential diagnosis of acute renal failure
associated with monoclonal gammopathy
Cast nephropathy or myeloma kidney
AL amyloidosis
LCDD
HCDD
Light chain Fanconi syndrome
Cryoglobulinemic or membranoproliferative glomerulonephritis
Immunotactoid glomerulonephritis
Waldenstro¨m’s macroglobulinemia
Crystal storing histiocytosis5
LCDD, light chain deposition disease; HCDD, heavy chain deposition disease.
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microscopy, glomerular amyloid appears as amorphous
material in the mesangium and capillary loops.7 The
mesangial involvement usually leads to the formation of
PAS-negative mesangial nodules. The glomerular capillary
walls are infiltrated with amyloid resulting in the thickening
of the glomerular basement membranes. On silver stains,
spicules can be seen. When the glomerulus is involved,
almost 50% of the cases present with renal insufficiency and
more then 70% have proteinuria.4,7 Vessels are also
commonly involved, initially in the media. Less commonly,
amyloid deposits in the tubular basement membrane leading
to tubular atrophy and interstitial fibrosis.4 When amyloid is
confined to the tubulointerstitium or vasculature, proteinuria
is minimal and reduced glomerular filtration rate is the
principal clinical manifestation.7 In our case there was no
glomerular or vascular involvement. To the best of our
knowledge there has been one previously reported case of
intratubular amyloidosis (discussed below).1
Rheumatoid arthritis and amyloidosis
Amyloidosis can be associated with RA; however, amyloidosis
associated with RA is AA and not AL. Non-AL forms of renal
amyloidosis can present with predominantly tubular or
interstitial involvement and a previous article reported a case
of tubular amyloidosis in a patient with RA.13 In our case, the
amyloid was AL amyloidosis and not AA amyloid since the
amyloid was positive for l-light chains (and negative for
k-light chains). A diagnosis of multiple myeloma was
confirmed subsequently on bone marrow biopsy. The patient
was told by his local rheumatologist that he likely has
rheumatoid arthritis; however his rheumatoid factor carried
out at our hospital was negative. In addition, the knee
aspiration showed amyloid fibrils indicating that the poly-
arthralgia and synovitis were secondary to joint amyloidosis
and not RA.
Pathophysiology of intratubular amyloidosis
The pathophysiology of intratubular amyloid remains
unclear since amyloid fibrils are large and likely not filtered
through the glomerular capillary walls. One has to assume
that the fibrils are formed inside the tubule either from
secreted protein by the tubular cells or from filtered light
chains. The later is more likely since it is the mechanism by
which intratubular casts are formed in multiple myeloma. In
their study, Melato et al.1 examined 30 autopsies in patients
who had multiple myeloma or monoclonal gammopathy of
undertermined significance. They found four cases of renal
tubular casts exhibiting the histochemical characteristics of
immunoamyloid. All patients had multiple myeloma with
light chains in the urine. None of the cases of monoclonal
gammopathies had tubular amyloid casts. The diagnosis of
tubular amyloid casts was based on Congo-red stains. Since
the tissue was obtained from autopsy specimens, immuno-
fluorescence and electron microscopy was not carried
out. Friman et al.14 reported a case of immunoglobulin D
myeloma associated with multiple extramedullary amyloid-
containing tumors and amyloid casts in the renal tubules.
These studies suggested that amyloid casts in the tubules
associated with multiple myeloma are derived from frag-
ments of filtered immunoglobulin light chains. Furthermore,
our case suggests that amyloid may have been formed
within the tubular epithelial cells from reabsorbed immuno-
globulin light chains and subsequently secreted into the
tubular lumen.
To summarize, we present an unusual case of AL
amyloidosis where amyloid was noted within renal tubules
as droplets and casts. From the pathology standpoint, intra-
tubular amyloidosis is rare but should be in the differential
diagnosis when tubular casts or protein reabsorption-like
droplets in tubular epithelial cells are PAS negative and are
comprised of monoclonal light chains on immunofluore-
scence studies. Congo-red stains and electron microscopy are
then required to confirm the diagnosis.
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